Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation
Author(s) -
Karl-Heinz Kuck,
Josép Brugada,
Alexander Fürnkranz,
Andreas Metzner,
Feifan Ouyang,
K.R. Julian Chun,
Arif Elvan,
Thomas Arentz,
Kurt Bestehorn,
Stuart J. Pocock,
Jean-Paul Albenque,
Claudio Tondo
Publication year - 2016
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1602014
Subject(s) - medicine , atrial fibrillation , hazard ratio , cardiology , clinical endpoint , radiofrequency ablation , ablation , pulmonary vein , catheter ablation , atrial tachycardia , confidence interval , atrial flutter , randomized controlled trial , surgery
Current guidelines recommend pulmonary-vein isolation by means of catheter ablation as treatment for drug-refractory paroxysmal atrial fibrillation. Radiofrequency ablation is the most common method, and cryoballoon ablation is the second most frequently used technology.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom